Earlier studies identified CRCs comprising the POU3F2, SOX2 and SALL2, OLIG2 TFs whose activities reprogrammed differentiated GBM cells into induced tumour propagating cells (TPCs). The gene discussed is SOX2; the disease is glioblastoma.